In recent years, the understanding about the different clinical phenotypes, diagnostic and
prognostic factors of myelin oligodendrocyte glycoprotein-antibody-associated disorders …

There is increasing knowledge on the role of antibodies against myelin oligodendrocyte
glycoprotein (MOG-abs) in acquired demyelinating syndromes and autoimmune …

Over the past few years, increasing interest in the role of autoantibodies against myelin
oligodendrocyte glycoprotein (MOG-abs) as a new candidate biomarker in demyelinating …

Objective The main objective was to compare clinical features, disease course, and myelin
oligodendrocyte glycoprotein (MOG) antibody (Ab) dynamics between children and adults …

Importance Myelin oligodendrocyte glycoprotein antibodies (MOG-Abs) are consistently
identified in a range of demyelinating disorders in adults and children. Current therapeutic …

Introduction While monophasic and relapsing forms of myelin oligodendrocyte glycoprotein
antibody associated disorders (MOGAD) are increasingly diagnosed world-wide, consensus …

Imaging plays a crucial role in differentiating the spectrum of paediatric acquired
demyelinating syndromes (ADS), which apart from myelin oligodendrocyte glycoprotein …

Purpose of review The purpose of this review is to summarize current understanding
regarding the treatment of myelin oligodendrocyte glycoprotein antibody (MOG-Ab) …

Background and Objective The spectrum of myelin oligodendrocyte glycoprotein (MOG)
antibody–associated disorder (MOGAD) comprises monophasic diseases such as acute …

Background Investigations of myelin oligodendrocyte glycoprotein (MOG) antibodies are
usually focused on demyelinating syndromes, but the entire spectrum of MOG antibody …